Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | 0 | 0 | 886 | 641 |
| Gross Profit | N/A | N/A | N/A | 886 | 641 |
| Operating Expenses | 31,562 | 24,431 | 21,678 | 19,795 | 21,418 |
| Operating Income | -31,562 | -24,431 | -21,678 | -18,909 | -20,777 |
| Other Income | 2,291 | 1,480 | 443 | -275 | 309 |
| Pre-tax Income | -29,271 | -22,951 | -21,235 | -19,184 | -20,468 |
| Net Income Continuous | -29,271 | -22,951 | -21,235 | -19,184 | -20,468 |
| Net Income | $-29,271 | $-22,951 | $-21,235 | $-19,184 | $-20,468 |
| EPS Basic Total Ops | -6.08 | -5.12 | -5.04 | -4.96 | -5.52 |
| EPS Basic Continuous Ops | -6.12 | -5.10 | -5.04 | -4.93 | -5.54 |
| EPS Diluted Total Ops | -6.08 | -5.12 | -5.04 | -4.96 | -5.52 |
| EPS Diluted Continuous Ops | -6.12 | -5.10 | -5.04 | -4.93 | -5.54 |
| EBITDA(a) | $-32,704 | $-24,834 | $-21,566 | $-18,469 | $-20,175 |